Forte Biosciences Inc

FBRX

Company Profile

  • Business description

    Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

  • Contact

    3060 Pegasus Park Drive
    Building 6
    DallasTX75247
    USA

    T: +1 310 618-6994

    https://www.fortebiorx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    16

Stocks News & Analysis

stocks

Netflix and Warner Bros. Discovery: Surprisingly high merger price alters shareholder value for both

Our view on the blockbuster merger.
stocks

The trillion-dollar club: Are these mega-sized stocks still buys?

The biggest stocks got bigger this year, breaking multi-trillion-dollar milestones.
stocks

New pricing model for embattled ASX tech leader

Investor day shows off potentially disruptive pricing model.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
Dow JONES (US)47,954.99104.050.22%
NASDAQ23,578.1372.990.31%
S&P 5006,870.4013.280.19%

Market Movers